The Regulatory Reality of 2026: What Actually Changed In late 2023, the FDA moved 19 peptides, including BPC-157, to what's known as "Category 2" status under its framework for bulk drug substances used in compounding, identifying them as substances that "may present significant safety risks." The concern, as stated in FDA guidance, centered on the limited large-scale human data and questions about immunogenicity
Manpreet, K.S
Almost anyone with a confirmed B12 deficiency, absorption challenges, or wellness goals can consider home injections
That three-layer testing protocol is unusual in the RUO space
Jung BG, Lee KO, Lee SS, Chi YH, Jang HH, Kang SS (2002) A Chinese cabbage cDNA with high sequence identity to phospholipid hydroperoxide glutathione peroxidases encodes a novel isoform of thioredoxin-dependent peroxidase
Therefore, the ratio of GSH and GSSG has been focused as an index of oxidative stress